E
Pulmonx Corporation LUNG
$3.26 -$0.055-1.66% NASDAQ
Recommendation
Prev Close
$3.32
Volume
391,454
Avg Vol (90D)
354,357
Market Cap
$133.45M
Dividend & Yield
--
52-Week Range
$3.31 - $9.41
P/E (TTM)
--
EPS (TTM)
-$1.45
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Pulmonx (LUNG, $3.32) Aroon Indicator entered a Downtrend on May 13, 2025.
5/14/2025 - Tickeron - Stocks
Pulmonx (LUNG, $3.32) RSI Indicator left the oversold zone on May 13, 2025
5/14/2025 - Tickeron - Stocks
Pulmonx (LUNG, $3.68) RSI Indicator left the oversold zone on May 12, 2025
5/13/2025 - Tickeron - Stocks
Pulmonx (LUNG, $3.68) Aroon Indicator entered a Downtrend on May 12, 2025.
5/13/2025 - Tickeron - Stocks
Deerfield Management Company L.P. Series C Purchases New Position in Pulmonx Co. (NASDAQ:LUNG)
5/10/2025 - MarketBeat
Pulmonx (LUNG, $3.37) Aroon Indicator entered a Downtrend on May 09, 2025.
5/10/2025 - Tickeron - Technical Analysis
Pulmonx (LUNG, $3.64) Aroon Indicator entered a Downtrend on May 08, 2025.
5/9/2025 - Tickeron - Stocks
Pulmonx (LUNG, $3.68) Aroon Indicator entered a Downtrend on May 07, 2025.
5/8/2025 - Tickeron - Technical Analysis
Pulmonx (LUNG, $3.44) Aroon Indicator entered a Downtrend on May 06, 2025.
5/7/2025 - Tickeron - Stocks
Pulmonx Corporation (NASDAQ:LUNG) Q1 2025 Earnings Call Transcript
5/6/2025 - Insider Monkey
Pulmonx (LUNG, $3.58) Aroon Indicator entered a Downtrend on May 05, 2025.
5/6/2025 - Tickeron - Technical Analysis
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pulmonx (LUNG) and Bristol-Myers Squibb (BMY)
5/5/2025 - TipRanks Financial Blog
61,405 Shares in Pulmonx Co. (NASDAQ:LUNG) Purchased by Susquehanna Fundamental Investments LLC
5/4/2025 - Ticker Report
D. Boral Capital Reaffirms Buy Rating for Pulmonx (NASDAQ:LUNG)
5/3/2025 - MarketBeat
Pulmonx (LUNG, $3.77) Aroon Indicator entered a Downtrend on May 02, 2025.
5/3/2025 - Tickeron - Stocks
Pulmonx (LUNG, $3.77) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 1, 2025
5/2/2025 - Tickeron - Technical Analysis
Pulmonx (LUNG, $3.77) Aroon Indicator entered a Downtrend on May 01, 2025.
5/2/2025 - Tickeron - Technical Analysis
Pulmonx (LUNG, $3.77) RSI Indicator left the oversold zone on May 01, 2025
5/2/2025 - Tickeron - Technical Analysis
Pulmonx (LUNG) Expected to Announce Quarterly Earnings on Wednesday
5/2/2025 - MarketBeat
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
5/1/2025 - GuruFocus
Pulmonx (LUNG) Price Target Lowered by Canaccord Genuity LUNG Stock News
5/1/2025 - GuruFocus
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
5/1/2025 - Globe Newswire
Pulmonx (LUNG): Analyst Lowers Price Target, Maintains Overweight Rating LUNG Stock News
5/1/2025 - GuruFocus
Pulmonx (LUNG) Maintains "Buy" Rating with Stable Price Target LUNG Stock News
5/1/2025 - GuruFocus
Pulmonx (LUNG) Target Price Adjusted by Piper Sandler Analyst LUNG Stock News
5/1/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$87.47M
EBITDA (TTM)
-$55.56M
EBIT (TTM)
-$57.73M
Net Income (TTM)
-$57.09M
Balance Sheet
Total Assets (Q)
$150.74M
Total Debt (Q)
$56.95M
Total Liabilities (Q)
$73.07M
Book Value Per Share (Q)
$1.93
Cash Flow
Cash from Operations (TTM)
-$32.96M
Cash from Investing (TTM)
$36.30M
Cash from Financing (TTM)
$1.16M
Net Change in Cash (TTM)
$4.42M
Filings
Filing Date
Friday, May 2, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Loading...
Beta
0.78
7-Day Total Return
-8.94%
30-Day Total Return
-52.55%
60-Day Total Return
-53.36%
90-Day Total Return
-50.00%
Year to Date Total Return
-50.00%
1-Year Total Return
-63.41%
2-Year Total Return
-75.17%
3-Year Total Return
-81.97%
5-Year Total Return
--
52-week Low
May 13, 2025 - $3.31
52-week High
May 16, 2024 - $9.41
Valuation
Market Cap
$133.45M - Micro Cap
Enterprise Value
$101.70M
Price/Sales (TTM)
1.51
Price/Book (Q)
1.72
Dividends and Shares
Shares Outstanding
39.95M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
pulmonx.com
Phone Number
650 364 0400
Address
700 Chesapeake Drive
Redwood City, CA 94063
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary... more
NASDAQ 05/14/2025 4:00PM Eastern Quotes delayed